research projects monash university

• Help & FAQ

Find Research Projects

Filters for projects.

• 1 - 50 out of 24,284 results
• Status, start date (ascending)

Search results

The dreamscape project: phenomenology and neurophysiology of dreams.

Windt, J. , Tsuchiya, N. & Andrillon, T.

Australian Research Council (ARC)

31/05/24 → 30/05/27

Project : Research

Data Driven Discovery of New Catalysts for Asymmetric Synthesis

Priebbenow, D. & Leitch, D.

Australian Research Council (ARC) , University of Victoria (Canada)

29/05/24 → 29/05/27

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults with Elevated Lipoprotein(a) who have Established Atherosclerotic Cardiovascular Disease or Are at Risk for a First Cardiovascular Event – ACCLAIM-Lp(a)

Nicholls, S.

24/05/24 → 23/05/29

P2.6 - Hydrobe Stage 3 Biomass valorisation

van 't Hag, L. , Anderson, D. & Webley, P.

23/05/24 → 31/12/24

A Two Part Phase IIa/b Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Dose-ranging Study to Assess Efficacy, Safety, and Tolerability of the Combination of Zibotentan and Dapagliflozin, and Dapagliflozin Monotherapy Versus Placebo in Participants with Cirrhosis with Features of Portal Hypertension (ZEAL Part B)

22/05/24 → 21/05/29

An open-label, single-arm, phase 2 trial of GlOfitamab and pIrtobrutinib (LOXo-305) in patients with mantle cell lymphoma and prior exposure to a BTK inhibitor

22/05/24 → 22/05/26

A Phase 3, Randomized, Multicenter, Double-Blind, Placebo- and Active Comparator-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-279 in Subjects With Moderate-to-Severe Plaque Psoriasis

Phase 3, randomized, multicenter, open-label study to evaluate the efficacy and safety of alnuctamab compared to standard of care regimens in participants with relapsed or refractory multiple myeloma (rrmm) - alumminate rrmm.

Spencer, A.

20/05/24 → 19/05/26

A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled and Deucravacitinib Active Comparator-controlled Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis

20/05/24 → 19/05/29

A Phase 2/3, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Oral Ozanimod (RPC1063) in Pediatric Participants with Moderately to Severely Active Crohn’s Disease with an Inadequate Response to Conventional Therapy

A phase iii, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy, safety, pharmacokinetics, and pharmacodynamics of satralizumab as monotherapy or in addition to baseline therapy in patients with myelin oligodendrocyte glycoprotein antibody-associated disease (mogad), an open-label, multiple-ascending dose, two-part dose ranging and cohort expansion study of ini-4001 in patients with advanced solid tumours.

19/05/24 → 18/05/26

Commonwealth Climate Resilience Network Grants Application

Narayan, S. & Dargusch, P. J.

Association of Commonwealth Universities

16/05/24 → 31/08/24

Novel Coating Technology for Stealth and Shielding Applications in Defence

Kashif, M. , Bach, U. , Mulvaney, P. & White, B.

16/05/24 → 16/11/25

Some like it hot: the genetics of rapid adaptation to climate change

Hodgins, K. , Connallon, T. , Uesugi, A., Wright , S. & Ellis, A. G.

15/05/24 → 14/05/27

Developing nutritional guidance, resources and a structured nutritional programme for boys with Duchenne Muscular Dystrophy to inform standards of care in the UK: A mixed-model study

Wong, J., Gerasimidis, K., Bray, L., Crabtree, N., Davidson, Z. , Malkova, D. & Billich, N. K.

15/05/24 → 15/05/27

Development of electro-catalysts for CO2 reduction study from flaring or post-combustion

Siang Piao, C. , Putri, L. , Lling Lling, T. & Meng Nan, C.

15/05/24 → 14/12/25

Numerical Modelling of Liquid Hydrogen (LH2) sloshing in Tanks and its Impact on Boil-Off Rates

Hughes, T. & Prakash, R.

15/05/24 → 1/05/28

The impact of two different stab vests compared to standard uniform on sweat responses and body temperature during rest and moderate intensity exercise in a hot environment

Caldwell Odgers, J.

Aquaterro Pty Ltd

15/05/24 → 30/10/24

Phase 3 Double-blind Multicenter Randomized Active-Controlled Study to Evaluate the Safety and Efficacy of Bictegravir/Lenacapavir Versus Biktarvy® (Bictegravir/Emtricitabine/Tenofovir Alafenamide) in Virologically Suppressed People With HIV-1

McMahon, J.

14/05/24 → 13/05/26

Volt AF Pivotal IDE Study

14/05/24 → 13/05/29

A randomized, double-blind, placebo-controlled Phase III clinical study evaluating the efficacy and safety of CBD TPM capsules in adults for use in the reduction of insomnia severity

Mansfield, D.

P2.4 – Industrial Bioprocess Scale-Up

Bhatelia, T., Webley, P. , Pareek, V., Wu, H., Anderson, D. & Gilbert, A.

Hydrobe Pty Ltd , Bioplatforms Australia Ltd , Curtin University

13/05/24 → 29/08/28

Ammonium-selective membranes to shift water industry into circular economy

Gao, L. & Wang, H.

13/05/24 → 12/05/27

Visit to research facilities in United Kingdom (Kings College London) and Switzerland (University of Basel) and ESO Conference (Basel, Switzerland)

Kilkenny, M.

National Heart Foundation of Australia

10/05/24 → 21/05/24

A Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Effect of Baxdrostat on Ambulatory Blood Pressure in Participants with Resistant Hypertension (Bax24)

9/05/24 → 8/05/29

P3.2B –CO2 Conversion SAF and Methanol

Bhatelia, T., Webley, P. & Kimber, J.

Wesfarmers Chemicals Energy & Fertilisers Limited , Curtin University

9/05/24 → 10/08/28

First-in-Human, Phase 1 Study of AMT-676, an Anti-CDH17 Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors

9/05/24 → 9/05/26

A Phase 1a/1b Open-label, Dose-Escalation and Expansion Study of ACTM-838 as a Single Agent in Patients with Advanced Solid Tumors

Haydon, A. & Brooks, C.

8/05/24 → 7/05/26

Practical Post-Quantum: Practical Post-Quantum Oblivious Pseudorandom Functions Supporting Verifiability

Esgin, M. & Steinfeld, R.

Amazon Web Services Inc (United States of America)

1/05/24 → 1/05/25

Implications of Global Economic Forces for Domestic Monetary Policy

Wong, B. , Du, Q. , Morley, J. & Haque, Q.

1/05/24 → 30/04/27

A Phase 1/2 Open-label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of PC14586 in Patients with Locally Advanced or Metastatic Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

1/05/24 → 30/04/29

A Phase 1a/1b Study of BG-68501, a Selective CDK2 Inhibitor, in Participants With Advanced Solid Tumors

Integrated systems immunology approach for identification of biomarkers of dengue hemorrhagic fever, development of patient decision aids to inform oral corticosteroid use in asthma and copd.

Jones, A. & Holland, A.

1/05/24 → 31/12/24

Automatic Design and Fabrication of Soft Robotic Grippers for Industrial Applications

Nurzaman, S. , Teh, P. , Goh, K. B. & Khoo, B. H.

30/04/24 → 29/10/25

(1) Strengthen the Nauru Green Climate Fund (GCF) National Designated Authority (NDA) capacities, formulate its readiness needs roadmap and finalise the Nauru GCF Country Programme under the Nauru GCF Readiness 2 Project; and (2) Nauru National Adaptation Planning Phase One Project

Dargusch, P. J. , Depaune, M., Yamuna, R., Nguyen, T., Wang, C. N., Newton Cain, T., Sexton, F., Gorman, H., Hill, G. & Deiye, T.

Secretariat of the Pacific Regional Environment Programme (SPREP)

30/04/24 → 13/09/24

Impact of roughness on adverse pressure gradient turbulent boundary layers

Soria, J. & Atkinson, C.

29/04/24 → 28/04/27

Development and Validation of Chronic Kidney Disease Predictive Model for the Malaysian Population

Lee, S. W. H. , Wong, Y. J. , Kumar, N., Hussein, Z., Aqilah, N. , Lim, S. K. & Loh, C. L.

29/04/24 → 28/04/26

Analysis and evaluation of the activities undertaken by the Peak Multicultural Organisations using the COVID-19 Vaccine Engagement Strategy, to increase COVID-19 vaccine uptake in Culturally and Linguistically Diverse (CALD) communities.

Skouteris, H. , Blewitt, C. , Bowden, M., Madill, R., Rakic, S. & Van Dyke, T.

29/04/24 → 13/09/24

Understanding Atopic Dermatitis Pathogenesis and Treatment Response through Multi-Omics Analysis

Kern, J. , Pattaroni, C. & Marsland, B.

24/04/24 → 30/04/27

Controllable quantum phases in two-dimensional metal-organic nanomaterials

Schiffrin, A. , MacLeod, J., Jelinek, P. & Bhattacharyya, S.

24/04/24 → 23/04/27

P2.1 – Two-step bioconversion of CO2 into methyl ketones and chemical refinement into jet fuel

Webley, P. , Ebert, B., Marcellin, E., Moghaddam, L. V., Rackemann, D., Konarova, M., van 't Hag, L. , Joshi, J. & Gilbert, A.

23/04/24 → 10/08/28

A Phase 1, Open-label Dose Escalation and Dose-Expansion Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of D3L-001 Monotherapy in Subjects with HER2-Positive Advanced Solid Tumors

23/04/24 → 23/04/26

PENAO Oral: ADME and PK Studies

Charman, S. , Shackleford, D. & Stupple, A.

22/04/24 → 21/04/25

A Phase 3, Randomized, Multicentre, Open-label Study to Evaluate the Efficacy and Safety of Alnuctamab Compared to Standard of Care Regimens in Participants with Relapsed or Refractory Multiple Myeloma (RRMM)- ALUMMINATERRMM

22/04/24 → 21/04/29

Understanding crack initiation in Ti-alloys in view of twisted grain boundaries

Preuss, M. , Azhari, F. , Agius, D. & Reja, K.

19/04/24 → 1/08/27

A Phase 3, Open-label Study of Adjunctive Ganaxolone (GNX) Treatment in Children and Adults with Tuberous Sclerosis Complex (TSC)-related Epilepsy

O'Brien, T.

19/04/24 → 19/04/26

The impact of circadian and sleep factors on neurodevelopment

Cropley, V., Bei, B. , Zalesky, A., Wilson Rajaratnam, S. , Stone, J., Ella Tian, Y. & Allen, N. B.

18/04/24 → 17/04/29

Developing vitrimers: next generation reusable plastics

Gresil, M. , Connal, L. A. & Tournilhac, F.

Australian Research Council (ARC) , Monash University – Internal School Contribution

18/04/24 → 17/04/27

/pubs/2019handbooks/units/MPH5231.html

Faculty of Medicine, Nursing and Health Sciences

• Skip to content
• Skip to navigation
• Current students
• Giving to Monash

MPH5231 - Research design and project proposal - 2019

6 points, sca band 2, 0.125 eftsl, postgraduate - unit.

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered.

Medicine, Nursing and Health Sciences

Organisational Unit

Department of Epidemiology and Preventive Medicine

Chief examiner(s)

Dr Sandra Braaf

Coordinator(s)

Unit guides

• First semester
• Second semester

Alfred Hospital

• First semester 2019 ( Off-campus )
• First semester 2019 (On-campus)
• Second semester 2019 ( Off-campus )
• Second semester 2019 (On-campus)

Prerequisites

Distinction (70-79%) or High Distinction (80% or higher) in MPH5040 and Distinction (70-79%) or High Distinction (80% or higher) in MPH5041 .

Co-requisites

Must be enrolled in one of the following course codes: 0046, 2311, 2312, 2872, M6008, M6024, M6028, M6026

This unit is designed to allow students to identify a research project in the field of population health or clinical research, confirm an appropriate supervisor, develop the research question and methodology, and commence the project, including obtaining ethics approval if relevant.

Upon successful completion of this unit, students should be able to:

• Describe the theoretical basis behind their topic and research design
• Synthesise critical arguments in relation to the existing literature about the topic
• Develop appropriate research questions, aims and hypotheses
• Demonstrate a collaborative and critical approach to research
• Identify the ethical and methodological issues related to the conduct of the proposed research
• Successfully complete and receive the necessary ethical and governance approvals for the conduct of their research (if required)
• Effectively manage time and resources to achieve pre-determined goals.
• Confirmation of supervisor (Hurdle)
• Project proposal including literature review (Hurdle)
• Ethics approval (project dependent) (Hurdle)

Workload requirements

Regular contact and consultation with supervisor either face to face or electronic.

6 hours per week for self-directed study and research related activities.

See also Unit timetable information

This unit applies to the following area(s) of study

Public health

Additional information on this unit is available from the faculty at:

http://www.med.monash.edu.au/epidemiology/pgrad

Net Zero Precincts Stage 2: Agenda-setting

Net Zero Precincts is a four-year Australian Research Council (ARC) Linkage project that brings together two key areas of research for the first time — transition management and design anthropology — to develop a new interdisciplinary approach to transitioning urban environments to net zero. The project uses the Monash University Clayton Campus and Monash Technology Precinct as an action-oriented Living Lab to experiment, test and learn in a real-world setting.

The project aims to develop and validate a new and transferrable approach for net-zero transitions informed by the real-life experiences of the precinct community and its businesses, government, knowledge sector and civil society actors. As such, it will provide significant benefits to organisations and individuals seeking to engage with and learn from everyday people about community needs and aspirations in accelerating urban transitions.

This report shares details of the interdisciplinary methods developed for Stage 2 of the Net Zero Precincts ARC Linkage project to answer the following question: How can the precinct community envision pathways to net zero precinct futures together in a way that balances net zero emissions with the everyday social, political and experiential realities of the community?

This report presents an overview of the envisioning process through five workshops with over 50 participants connected to Monash University Clayton Campus and the Monash Technology Precinct from July 2023 to March 2024. The workshops were designed to enable research participants to reflect on the ethnographic insights from Stage 1, experience transitions-in-the-making through embodied learning, understand transition dynamics and co-create diverse and inclusive future visions and pathways.

This report takes the essential step in establishing how to explore and understand the concepts and practices of design anthropology which both complicates and creates new possibilities for transition management and the creation of net zero futures.

Net Zero Precincts: an interdisciplinary approach to decarbonising cities

Australian Research Council

Usage metrics

Monash Climate Change Communication Research Hub (Malaysia Node), MSCA Global Postdoctoral Fellowship: Call for First-Stage Applications

Job Information

Offer description.

The Monash Climate Change Communication Research Hub (MCCCRH) investigates how to support effective communication to adapt to a changing climate and implement climate solutions. MCCCRH comprises experts from across the Monash University campuses in Australia, Malaysia, Indonesia and Italy, ensuring local knowledge and global reach.

The MCCCRH Malaysia Node was established in 2021 and sits within the School of Arts and Social Sciences (SASS) at Monash University Malaysia. The node researches public attitudes towards climate change, and ways to better communicate the science and solutions, with a geographical focus on Southeast Asia.

The MCCCRH Malaysia Node is calling for first-stage applications from postdoctoral scholars who wish to be based at the node as part of a Marie Skłodowska-Curie Actions (MCSA) Global Postdoctoral Fellowship , funded by Horizon Europe.

The MSCA Global Postdoctoral Fellowship allows European nationals or long-term residents to engage in research projects with organisations outside EU Member States and Horizon Europe Associated Countries.These fellowships require an outgoing phase of 12 to 24 months in a non-associated Third Country , such as Malaysia, and a mandatory 12-month return phase to a host organisation based in an EU member state or a Horizon Europe Associated Country .

See here for a current list of non-associated Third Countries (“Other Third Countries”) that can host the outgoing phase, and Horizon Europe Associated Countries (“Third Countries Associated with Horizon Europe”) that, along with EU member states, can host the return phase.

The MCCCRH Malaysia Node welcomes applications from eligible researchers who wish to be based at the Node for 12 to 24 months in the outgoing phase. You must be in possession of a PhD and have a maximum of 8 years’ full-time equivalent (FTE) experience in research from the date of award of your PhD.

We welcome applications for research in the following areas, with an emphasis on Southeast Asia, especially Malaysia. Comparative studies of these issues between Malaysia and the applicant’s host organisation country are especially welcome:

• the relationship between climate change communication and climate action
• public perceptions of climate change as an enabler of or barrier to climate action
• climate and health literacy, including mental health  
• narrative and literary expressions of climate change, e.g. climate stories, climate fiction, and climate poetry

In the first instance, the application is in the form of an Expression of Interest , which includes:

copy of PhD certificate

research proposal (max. 1000 words) outlining the research project and timeline with details of time to be spent on the outgoing and return phases

evidence (in the form of a letter of support on official letterhead) of willingness from a research or higher education organisation based in an EU member state or a Horizon Europe Associated Country to be a host organisation for the return phase

• the names of two referees (at least one should be from an organisation other than your proposed host organisation)

The deadline is 21 June 2024 . 

Following this first stage, the MCCCRH Malaysia Node will work with successful applicants and their host organisation to prepare an application to the MSCA Post-doctoral Fellowship scheme by 11 September 2024. Please note that we cannot guarantee successful first-stage applicants that they will then be successful in the MCSA Global Fellowship selection process.

See here for more information on the MCCCRH and the Malaysia Node .

For further information on this call, contact Professor Adeline Johns-Putra, Chair of the MCCCRH (Malaysia Node): [email protected]

Requirements

Additional information, work location(s), where to apply.

• Andhra Pradesh
• Arunachal Pradesh
• Chhatisgarh
• Himachal Pradesh
• Jammu and Kashmir
• Madhya Pradesh
• Maharashtra
• Uttar Pradesh
• Uttarakhand
• West Bengal
• Movie Reviews
• DC Comments
• Sunday Chronicle
• Hyderabad Chronicle
• Editor Pick
• Special Story

India-Australia Alliance: Critical Minerals Research Hub Approved

Hyderabad: In a move towards establishing a sustainable global supply chain for critical minerals, the Union education ministry approved a joint initiative between Monash University and IIT Hyderabad on Saturday. The Australia-India Critical Minerals Research Hub (AICMRH) aims to enhance research and development in the extraction and processing of critical minerals, focusing on sustainable practices and supply chain analyses, an official press statement said.

The education ministr, in collaboration with the Centre, has formed the empowered committee for industry and international collaborations (ECIIC). Among the 12 themes identified by the ECIIC, critical minerals have been highlighted as a priority, with IIT Hyderabad chosen to spearhead the nation’s efforts in this domain.

The initiative is supported by a proposal from the Society for the Promotion of Area Resource Centres (SPARC), jointly led by IIT Hyderabad and Monash University. The project, which brings together various Indian and Australian universities, R&D labs, and industries, has recently received MoE approval along with funding of $1.15 million. This initiative is poised to bolster India-Australia collaborations in the field of critical minerals.

Latest News

Find Info For

• Current Students
• Prospective Students
• Research and Partnerships
• Entrepreneurship and Commercialization
• Office of Engagement

Quick Links

• HLA Department Site
• College of Agriculture
• Purdue Extension

Dr. Ying Li’s Project Awarded IPAI Postdoctoral Research Award

It is the policy of the purdue university that all persons have equal opportunity and access to its educational programs, services, activities, and facilities without regard to race, religion, color, sex, age, national origin or ancestry, marital status, parental status, sexual orientation, disability or status as a veteran. purdue is an affirmative action institution. this material may be available in alternative formats., purdue sites purdue sites.

• Purdue Homepage
• Employee Portal
• Purdue Today
• Campus Directory
• University Calendar

College of Agriculture Sites College of Agriculture Sites

• College of Ag Homepage
• Education Store
• Extension Events

© 2024 Purdue University | An equal access/equal opportunity university | Copyright Complaints | Maintained by HLA Happenings

If you have trouble accessing this page because of a disability, please contact HLA Happenings at [email protected] | Accessibility Resources